Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Huateng Pharma Introduces Piroctone Olamine: A New Solution for Fungal Infections and Dandruff Control

    May 20, 2024, 08:13 AM by
    Huateng Pharma, a leader in innovative pharmaceutical solutions, is excited to announce the launch of its latest product, Piroctone Olamine (CAS No. 68890-66-4).
    Full story
  • Biopharma PEG to Showcase Innovative PEG Derivatives at BIO 2024 in San Diego

    May 20, 2024, 08:13 AM by
    Biopharma PEG, a renowned leader in the development and supply of high-quality polyethylene glycol (PEG) derivatives, is pleased to announce its participation in the BIO International Convention 2024. The event will take place from June 3-6, 2024, at the San Diego Convention Center, and attendees can visit Biopharma PEG at Booth 5102.
    Full story
  • Lindus Health Announces Cosmetics Clinical Trial with Acinonyx Bio to Evaluate an Alternative to Benzoyl Peroxide for Inflammatory Acne

    May 17, 2024, 07:46 AM by
    https://www.prnewswire.com/news-releases/lindus-health-announces-cosmetics-clinical-trial-with-acinonyx-bio-to-evaluate-an-alternative-to-benzoyl-peroxide-for-inflammatory-acne-302146936.html?tc=eml_cleartime
    Full story
  • IntelliGuard Appoints Seasoned Leader as New Chief Product Officer for Enhanced Healthcare Solutions

    May 17, 2024, 07:46 AM by
    Rob Sobie to support IntelliGuard’s ongoing innovation to track, trace, and improve safety in medication inventory
    Full story
  • Phenomix Sciences Raises $7.8M in Funding to Accelerate Adoption of Obesity Precision Medicine

    May 17, 2024, 07:46 AM by
    Precision medicine biotechnology company for obesity secures additional institutional capital from prominent industry leaders to expand the use of its novel phenotyping test and advance clinical research in weight loss treatment.
    Full story
  • MDClone Earns Fourth Consecutive "Best Healthcare Big Data Platform" Award from MedTech Breakthrough

    May 17, 2024, 07:46 AM by
    https://www.prnewswire.com/news-releases/mdclone-earns-fourth-consecutive-best-healthcare-big-data-platform-award-from-medtech-breakthrough-302147956.html?tc=eml_cleartime
    Full story
  • Prebiotic Fibre Supplement Significantly Reduces Risk of Developing Type 2 Diabetes, UK Study Finds

    May 17, 2024, 07:46 AM by
    Today, The British Journal of Nutrition published a study that found the consumption of a daily prebiotic fibre supplement helped to improve insulin sensitivity and other important health markers in patients with pre-diabetes
    Full story
  • Alfa Chemistry Debuts Shape Memory Alloys, Nitinol SMAs, and 3D Printing Alloys

    May 17, 2024, 07:46 AM by
    Full story
  • Mural Health Named “Most Innovative Start-up” at the 2024 Citeline Awards

    May 16, 2024, 08:08 AM by
    Mural Health Named “Most Innovative Start-up” at the 2024 Citeline Awards
    Full story
  • Icosagen and Lead Discovery Center Announce Collaboration to Discover Novel Monoclonal Antibodies

    May 16, 2024, 08:08 AM by
    Icosagen announces a strategic partnership on selected projects with Lead Discovery Center GmbH (LDC) to discover novel monoclonal antibodies.
    Full story
  • Integrated DNA Technologies and Molecular Health Ink Commercial Partnership

    May 16, 2024, 08:08 AM by
    IDT and Molecular Health have entered into a global multi-year agreement, starting in the U.S., to integrate their NGS capabilities.
    Full story
  • Inceptua Group Expands Early Access Program to Latin America

    May 16, 2024, 08:08 AM by
    Inceptua Group announces an expansion of an Early Access Program for cefiderocol for eligible patients in Argentina, Chile, Colombia, Guatemala, Mexico, and Panama.
    Full story
  • Vector Laboratories Merges With Absolute Biotech, Significantly Expanding Capabilities as a Critical Component Manufacturer for Life Science Customers

    May 16, 2024, 08:08 AM by
    Vector Laboratories joins forces with Absolute Biotech, bolstering its role as a key manufacturer for life science customers, enriching its antibody reagents portfolio, and expanding its commercial presence into the UK and EU.
    Full story
  • Liquid Biopsy Under Development for Measuring Drug Response

    May 16, 2024, 05:00 AM by User Not Found
    Bio-IT World | The lab of W. Andy Tao, professor of biochemistry at Purdue University, is pioneering a way to assess drug response based on metabolizing proteins found in circulating extracellular vesicles (EVs), which could serve as a surrogate of their expression level in the liver and become therapeutic targets for some cancers.
    Full story
  • Indica Labs Receives First FDA Clearance for HALO AP Dx Digital Pathology Platform

    May 15, 2024, 08:31 AM by
    Indica Labs announced today that it received FDA clearance for HALO AP Dx, an enterprise digital pathology platform, for primary diagnosis.
    Full story
  • PrecisionLife and Metrodora Institute Launch Clinical Trials to Accelerate the Diagnosis and Treatment of ME/CFS and Long Covid Patients

    May 15, 2024, 08:31 AM by
    Metrodora Institute and PrecisionLife announce the start of recruitment on a cohort of up to 1,000 patients into clinical trials to evaluate new diagnosis and treatment options for ME/CFS, Long Covid, and related disorders.
    Full story
  • Elegen Raises $35 Million in Series B to Accelerate Expansion into Clinical Manufacturing

    May 15, 2024, 08:31 AM by
    Elegen is leveraging their next-generation DNA synthesis and production technology to expand into clinical DNA scaleup and manufacturing, a move supported by this Series B round with new investors Trianomic Capital, GSK, and Aldevron co-founder John Ballantyne as well as existing investors. This expansion into clinical applications comes just a little over a year after launching their first product, ENFINIA DNA. To date the company has rapidly enhanced its platform to speed the upstream discovery phase of genetic medicine development, and in January announced a collaboration and licensing agreement with GSK. Investors are confident that Elegen's cell-free, turnkey synthetic DNA platform will transform the speed and reliability of clinical GMP DNA manufacturing.
    Full story
  • ZeOmega Supports Health Plan Alliance with Payvider Solutions 

    May 15, 2024, 08:31 AM by
    Full story
  • Kalderos Names Healthcare Industry Veteran Daryl Todd as Chief Strategy Officer

    May 15, 2024, 08:31 AM by
    Kalderos Names Healthcare Industry Veteran Daryl Todd as Chief Strategy Officer
    Full story
  • InsightRX Continues Momentum in Precision Dosing with Client Growth, New Scientific Breakthroughs

    May 15, 2024, 08:31 AM by
    InsightRX Continues Momentum in Precision Dosing with Client Growth, New Scientific Breakthroughs
    Full story
  • «
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38 (current)
  • 39
  • 40
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy